(Q54061085)
Statements
Phase I study of paclitaxel in combination with a multidrug resistance modulator, PSC 833 (Valspodar), in refractory malignancies. (English)
1 reference
P M Fracasso
1 reference
P Westervelt
1 reference
C L Fears
1 reference
D M Rosen
1 reference
E G Zuhowski
1 reference
L A Cazenave
1 reference
M Litchman
1 reference
M J Egorin
1 reference
1 March 2000
1 reference
18
1 reference
5
1 reference
1124-1134
1 reference
Identifiers
1 reference